EU investigates drugmakers in antitrust probe

01/16/2008 | NYTimes.com · Wall Street Journal (free content), The

European Union antitrust officials are investigating whether drug companies, including Pfizer, AstraZeneca PLC, Sanofi-Aventis SA and GlaxoSmithKline PLC, have tried to keep generic or rival drugs off the market. "Without new pharmaceuticals, the quality of some medical treatments will stagnate; without generic products, the cost of some medical treatments will remain high," EU antitrust chief Neelie Kroes said.

View Full Article in:

NYTimes.com · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ